Bracco Diagnostics

107 College Road East

Princeton, NJ 08540

USA

Phone: (877) 272-2269

Fax: (866) 272-1619

[email protected]

Visit Website

RELATED CONTENT

With its latest evolution, Guerbet reports that it offers advanced performance features to its Optistar Elite.

Feature | Contrast Media Injectors | By Christine Book

Market Analysis: Vendor Focus on Optimizing Patient Safety and ...

Contrast media injectors are used to inject contrast media or contrast agents to enhance the blood and perfusion in ...

January 17, 2024

Following the positive opinion of the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA), and the recommendation sent by EMA to the European Committee (EC), the EC has granted Marketing Authorisation for Vueway (gadopiclenol) in the European Union

News | Contrast Media

The European Commission Grants Marketing Authorization to Bracco ...

December 11, 2023 — Bracco Imaging S.p.A., an innovative world leader delivering end-to-end products and solutions ...

December 11, 2023

Leaders in radiology will share insights on VUEWAY (gadopiclenol) solution for injection after the first year of use in the US

News | Contrast Media

Bracco Diagnostics Showcases Innovation and Collaborative Vision at ...

November 13, 2023 — Bracco Diagnostics Inc., the U.S. subsidiary of Bracco Imaging S.p.A., a pioneer in diagnostic ...

November 13, 2023

Feature | Radiation Dose Management | By Melinda Taschetta-Millane

5 Trends in Radiation Dose Management

Early-stage detection is key to the prevention of life-threatening diseases; however, limited access to data hinders the ...

September 20, 2023

FDA-approved in May 2023, POSLUMA is commercially available through 36 radiopharmacies across the United States

News | Prostate Cancer

Blue Earth Diagnostics Announces Addition of POSLUMA (Flotufolastat F ...

July 28, 2023 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization ...

July 28, 2023

177Lutetium-labeled radiohybrid (rh) Prostate-Specific Membrane Antigen (177Lu-rhPSMA-10.1) is an optimized, next generation therapeutic radiopharmaceutical

News | SNMMI

Blue Earth Therapeutics Announces Results of Early Clinical and ...

June 29, 2023 — Blue Earth Therapeutics, a Bracco company and emerging leader in the development of innovative next ...

June 29, 2023

Therapeutically equivalent and fully substitutable to Kinevac (Sincalide for Injection) formulated, filled and packaged in the United States provides health care facilities with choice and value

News | Contrast Media

Fresenius Kabi Broadens Radiology Portfolio with its First-to-Market ...

June 21, 2023 — Fresenius Kabi, a leading provider of injectable medicines, announced today it has launched the ...

June 21, 2023

POSLUMA is now commercially available in multiple U.S. radiopharmacies, with nationwide availability by end of June 2023

News | Prostate Cancer

Blue Earth Diagnostics and PETNET Solutions Inc, A Siemens ...

June 21, 2023 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization ...

June 21, 2023

VUEWAY (gadopiclenol) solution for injection and VUEWAY (gadopiclenol) Pharmacy Bulk Package are available for use in the U.S. following the market launch in February 20231

News | Contrast Media

American College of Radiology Classifies VUEWAY as a Group II Agent ...

May 16, 2023 — Bracco Imaging, an innovative world leader delivering end-to-end products and solutions through a ...

May 16, 2023

Sponsored Content | Videos | Contrast Media

VIDEO: Talking Trends with Bracco: Investing in the Future of ...

Bracco Diagnostics and Guerbet recently announced they had formed a strategic, global collaboration for the research ...

February 27, 2023

Bracco Diagnostics

You're about to leave ITN

RELATED CONTENT